Join us

2021 – A VERY STRONG YEAR FOR RHEI LIFE

Share This Post

Share on facebook
Share on linkedin
Share on twitter

In 2021, Rhei Life demonstrated great strength in a challenging market environment, generating growth across all divisions.

During the 2021, Rhei Life delivered strong results achieving triple-digit growth driven by the strong development across all three divisions – Consumer Healthcare Products, Hospital Medicines and Unregistered Medicines.

 

„ The unique ways in which our teams are contributing, stand behind this success. Our company is poised for sustainable growth, and we will continue to deliver cutting edge solutions for patients, partners and customers worldwide. We are determined to continue investing in those well-defined growth pillars that make Rhei Life stronger. Together with our industry peers and partners, we shall continue to outperform the market “, said Milos Stakić, Rhei Life CEO.

 

Rhei Life achieved exceptional growth in 2021, across divisions of Consumer Healthcare Products, Hospital Medicines and Unregistered Medicines. Our products generated more than 10m EUR of wholesale value in 2021, representing a triple-digit growth compared to the previous year. So far, we have been granted 90+ SKUs marketing authorizations in multiple markets for all kinds of products (Rx, Hospital Medicines, OTC Medicines, Food Supplements, Medical Devices) while 50+ SKUs have been submitted for new registrations.

 

Through our 5-year strategy, we shall follow the way to sustainable growth with a goal of 100mEUR revenue in 2026. In addition to our existing facilities in Serbia and Slovenia, we have opened a new one in Bosnia and Herzegovina. Our Slovenian company has been granted the EU GDP certificate allowing us to fully gain access to the entire EU market. On the other hand, our Serbian company is due to receive a license for a small manufacturing site that has recently been established for secondary packaging and batch release. This upgrade of our infrastructure enables us to act as European batch release company and a single point of contact for all non-EU manufacturers willing to enter EU markets in the most efficient way, fully supported by our Qualified Person for Batch Release.
Finally, in 2021, we welcomed 14 new colleagues and established 22 new partnerships.

 

Going forward, Rhei Life shall continue to act as a trusted partner and solution provider across the world, with a clear mission of improving people’s lives.

Mask Group 55@3x

Miloš Stakić

Chief executive officer